Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Surgical Oncology|September 30, 2010
Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgeryJ P Grabowski, P Harter, C Buhrmann, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Sexual Function, Sexual Activity and Quality of Life in Women with Ovarian and Endometrial CancerP Harter, I Schrof, L M Karl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignanciesA du Bois, J Huober, P Stopfer, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian CancerP Harter, S Mahner, F Hilpert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Neoadjuvant chemotherapy in ovarian cancer revisitedS Mahner, F Trillsch, D Chi, et al.
Journal of Clinical Pathology|January 8, 2009
VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resectionK Engels, A du Bois, P Harter, et al.
Gynecologic Oncology|October 18, 2015
Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directionsS Lheureux, K Karakasis, P Harter, et al.
Radiology|February 1, 1983
Ultrasonic evaluation of common bile duct stones: prospective comparison with endoscopic retrograde cholangiopancreatographyB H Gross, L P Harter, R M Gore, et al.
Archives of Gynecology and Obstetrics|January 23, 2018
The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)", the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic OncologyA M Dueckelmann, D Fink, P Harter, et al.
Archives of Gynecology and Obstetrics|February 16, 2018
Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO SwitzerlandA M Dueckelmann, D Fink, P Harter, et al.
Pageof 7